RMRC Bhubaneswar develops next-gen malaria vaccine; allows tech transfer for commercialisation

RMRC Bhubaneswar develops next-gen malaria vaccine; allows tech transfer for commercialisation

RMRC Bhubaneswar has developed AdFalciVax, a next-gen malaria vaccine, and is offering tech transfer for its commercialisation, marking a significant advancement in combating Plasmodium falciparum.